Cannabinoid receptor 2 selective agonist alleviates systemic sclerosis by inhibiting Th2 differentiation through JAK/SOCS3 signaling.
Tian N, Cheng H, Du Y, Wang X, Lei Y, Liu X, Chen M, Xu Z, Wang L, Yin H, Fu R, Li D, Zhou P, Lu L, Yin Z, Dai SM, Li B.
Tian N, et al. Among authors: fu r.
J Autoimmun. 2024 May 25;147:103233. doi: 10.1016/j.jaut.2024.103233. Online ahead of print.
J Autoimmun. 2024.
PMID: 38797049